Snehal patel greenwich lifesciences

Author: sxxs

August undefined, 2024

WebGreenwich LifeSciences went public in September at an IPO price of $5.75, raising the firm $7.25 million in proceeds. ... Greenwich LifeSciences CEO Snehal Patel estimated that GP2 could reach a ... Web13 Mar 2024 · Snehal S. Patel is the CEO, CFO & Director at Greenwich LifeSciences. What is the salary of Ms Patel? As the CEO and CFO & Director of Greenwich LifeSciences, the …

Greenwich LifeSciences CEO Interview to Air on Bloomberg ... - Nasdaq

Web29 Jan 2024 · Company Contact Snehal Patel Investor Relations (832) 819-3232 [email protected] Investor & Public Relations Contact for Greenwich LifeSciences Dave Gentry RedChip Companies... Web5 Jan 2024 · Even if it's not a huge purchase, we think it was good to see that Snehal Patel, the CEO, CFO & Director of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) recently shelled … freezing weather factor

Insider Buying: The Greenwich LifeSciences, Inc. (NASDAQ:GLSI) …

Web14 Apr 2024 · The Last 12 Months Of Insider Transactions At Greenwich LifeSciences Notably, that recent purchase by CEO, CFO & Director Snehal Patel was not the only time they bought Greenwich LifeSciences shares this year. They previously made an even bigger purchase of US$265k worth of shares at a price of US$9.13 per share. Web3 Dec 2024 · Snehal Patel Investor Relations (832) 819-3232 [email protected] Investor & Public Relations Contact for Greenwich … Web3 Feb 2024 · Greenwich LifeSciences, Inc. announced that Snehal Patel, CEO of Greenwich LifeSciences, will present in-person at 2:30 pm ET on February 14, 2024 at the 2024 BIO CEO & Investor Conference and will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the … freezing weather clip art

snehal patel - CEO - SPC Lifesciences Pvt. Ltd. LinkedIn

SNEHAL PATEL / ceowatcher

Web6 Sep 2024 · Greenwich LifeSciences, Inc. is a one-man, one-asset shop. The asset, GP2, has produced excellent breast cancer data. Greenwich LifeSciences' CEO, Snehal Patel, runs this company almost... Web29 Jan 2024 · Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer … freezing weather clipartWeb14 Apr 2024 · Greenwich LifeSciences, Inc. ( NASDAQ:GLSI – Get Rating) CEO Snehal Patel bought 5,000 shares of the company’s stock in a transaction dated Tuesday, April 11th. … fastball st albert

"WebI have reviewed this annual report on Form 10-K of Greenwich LifeSciences, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or … " - Snehal patel greenwich lifesciences

Snehal patel greenwich lifesciences

Greenwich LifeSciences Announces Acceptance of Two Posters ... - BioSpace

Web6 Apr 2024 · Significant control over Greenwich LifeSciences by retail investors implies that the general public has more power to influence management and governance-related decisions A total of 9 investors have a majority stake in the company with 52% ownership Insiders have bought recently Every investor in ... Web27 Jun 2024 · Ms Patel GLSI stock SEC Form 4 insiders trading. Ms has made over 19 trades of the Greenwich LifeSciences stock since 2024, according to the Form 4 filled …

Did you know?

Web6 Apr 2024 · Significant control over Greenwich LifeSciences by retail investors implies that the general public has more power to influence management and governance-related … Web14 Apr 2024 · The Last 12 Months Of Insider Transactions At Greenwich LifeSciences Notably, that recent purchase by CEO, CFO & Director Snehal Patel was not the only time …

Web14 Apr 2024 · Greenwich LifeSciences, Inc. ( NASDAQ:GLSI – Get Rating) CEO Snehal Patel bought 5,000 shares of the company’s stock in a transaction dated Tuesday, April 11th. The stock was bought at an... Web8 Dec 2024 · Snehal Patel Investor Relations Office: (832) 819-3232 Email: [email protected] Investor & Public Relations Contact for Greenwich …

Web1 Mar 2024 · To assess the safety profile of GP2 3. To monitor immunologic responses to treatment and assess relationship to efficacy and safety Contact information: Snehal … WebSnehal S. Patel holds the position of Chief Executive & Financial Officer, Director at Greenwich LifeSciences, Inc. Mr. Patel received an undergraduate degree from …

Web14 Apr 2024 · Greenwich LifeSciences, Inc. ( NASDAQ:GLSI – Get Rating) CEO Snehal Patel acquired 5,000 shares of the company’s stock in a transaction dated Tuesday, April 11th. The stock was bought at an...

Web15 Mar 2024 · Snehal Patel is the largest individual Greenwich Lifesciences shareholder, owning 6.78M shares representing 52.77% of the company. Snehal Patel's Greenwich Lifesciences shares are currently valued at $88.28M. If you're new to stock investing, here's how to buy Greenwich Lifesciences. freezing wax out of candleWeb27 Jan 2024 · SNEHAL PATEL. CEO and CFO at Greenwich LifeSciences, Inc. 3M Return: 190% ($4M) 3M Win Rate: 59% (13 of 22) 1Y Return: 460% ($11M) 1Y ... Stock Grant: … freezing weather gif fastball speed recordWebFirstName LastNameSnehal Patel Comapany NameGreenwich LifeSciences, Inc. June 25, 2024 Page 2 FirstName LastName Snehal Patel Greenwich LifeSciences, Inc. June 25, … fastballs pokemonWeb23 Jun 2024 · Management is headed by Mr. Snehal Patel, who has been with the firm since 2010 and was previously a consultant to various biotech companies and worked in operations and business development at... freezing weather conditionsWeb23 Apr 2024 · Greenwich LifeSciences Insider Transactions Over The Last Year In fact, the recent purchase by CEO, CFO & Director Snehal Patel was not their only acquisition of … fastball sweetwater texasWebGreenwich LifeSciences's Chief Executive Officer, Director is Snehal S. Patel. Other executives include F. Joseph Daugherty, Chief Medical Officer, Director; Jaye Thompson, … fastball the way cifra